Daphne R. Friedman, MD
Department / Division
Medicine /
Medicine - Oncology
Address
DUMC 3872
Durham, NC 27710
Appointment Telephone
Not accepting patients
Office Telephone
919-684-8964
Fax Telephone
919-684-5325
- MD, University of Maryland School of Medicine, 2002
- Internal Medicine, University of Maryland Medical Center, 2002-2005
- Hematology and Medical Oncology, Duke University Medical Center, 2005-2008
Clinical Interests
Care of patients with hematologic cancers, research in improving treatment and outcomes in hematologic cancers, particularly chronic lymphocytic leukemia; research in survivorship issues
Research Interests
My area of expertise is in leukemias and lymphomas, specifically Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. My research interests are focused on improving treatment options for patients with hematologic malignancies, by 1) identifying promising new agents and testing them in the laboratory, 2) developing biomarkers that can predict treatment sensitivity and response, and 3) translating these findings into the clinic by performing clinical research trials.
This physician has no reported relationships with industry.
Representative Publications
Friedman DR, Weinberg JB, Barry WT, Goodman BK, Volkheimer AD, Bond KM, Chen Y, Jiang N, Moore JO, Gockerman JP, Diehl LF, Decastro CM, Potti A, Nevins JR. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin Cancer Res. 2009 Nov 15;15(22):6947-55.
(2009)
Abstract
Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G, Lugar PL, Lagoo AS, Rizzieri DA, Friedman DR, Weinberg JB, Lipsky PE, Dave SS. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood. 2009 May 7;113(19):4586-94.
(2009)
Abstract
Weinberg JB, Volkheimer AD, Chen Y, Beasley BE, Jiang N, Lanasa MC, Friedman D, Vaccaro G, Rehder CW, Decastro CM, Rizzieri DA, Diehl LF, Gockerman JP, Moore JO, Goodman BK, Levesque MC. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol. 2007 Dec;82(12):1063-70.
(2007)
Abstract
